Evaluation of prognostic factors for high-risk classical Hodgkin lymphoma undergoing autologous transplantation.
Epperla N, Huang Y, Cashen AF, Vaughn JL, Hanel W, Badar T, Barta SK, Caimi PF, Sethi TK, Reddy N, Karmali R, Bello C, Chavez JC, Kothari SK, Hernandez-Ilizaliturri FJ, Svoboda J, Lansigan F, Glenn MJ, Cohen JB, Sorge C, Christian B, Herrera AF, Hamadani M, Costa LJ, Xavier AC.
Epperla N, et al. Among authors: herrera af.
Blood Adv. 2024 Aug 30:bloodadvances.2024013743. doi: 10.1182/bloodadvances.2024013743. Online ahead of print.
Blood Adv. 2024.
PMID: 39213424